Samlyn Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-192,325
| Closed | -$18.5M | – | 173 |
|
|
2020
Q3 | $18.5M | Buy |
+192,325
| New | +$18.5M | 0.33% | 73 |
|
|
2019
Q3 | – | Sell |
-387,897
| Closed | -$32.8M | – | 116 |
|
|
2019
Q2 | $32.8M | Buy |
+387,897
| New | +$32.8M | 0.69% | 48 |
|
|
2017
Q2 | – | Sell |
-92,983
| Closed | -$4.03M | – | 133 |
|
|
2017
Q1 | $4.03M | Buy |
+92,983
| New | +$4.03M | 0.09% | 110 |
|
|
2016
Q3 | – | Sell |
-168,000
| Closed | -$7.64M | – | 130 |
|
|
2016
Q2 | $7.64M | Buy |
+168,000
| New | +$7.64M | 0.18% | 81 |
|